Drug Testing at Home and The Opioid Crisis

Drug Testing at Home and The Opioid Crisis

At Home Drug Testing and The Future of Telemedicine

“Before the first COVID-19 case in the United States, a different epidemic—the opioid crisis—was taking the lives of 130 Americans per day. Although the pandemic threatens everyone, it is a particularly grave risk to the millions of Americans with opioid use disorder, who—already vulnerable and marginalized—are heavily dependent on face-to-face health care delivery.”

According to the National Survey on Drug Use and Health (NSDUH), 19.7 million American adults (aged 12 and older) battled a substance use disorder in 2017.

Could the relative risk of patients with substance use disorder who are not receiving the standard of care intersect with the relative risk of COVID-19?

LEARN MORE ABOUT AT HOME DRUG TESTING BY CONTACTING US: https://genotoxlabs.com/contact-us/

No Contact Drug Testing


At Genotox Laboratories, we’re devoted to providing healthcare professionals with accurate, dependable, and actionable toxicology and pharmacogenetics services. We serve pain physicians, family practices, internal medicine, psychiatrists, addiction specialists, OB/GYN, and recovery centers.

With 27 combined years of experience as a board-certified anesthesiologist and pain medicine physician, Matthew McCarty, MD became aware of the growing need for enhanced medication monitoring and personalized medicine. As a result, he founded Genotox Laboratories in 2012.

After extensive use of toxicology testing in his practice, Dr. McCarty realized that a better screening assay was essential for verifying UDT sample authenticity. Leveraging the power of molecular diagnostic testing, he invented and co-developed ToxProtect, the first patent pending DNA-authenticated urine drug test.

TAGS: Remote Urine Test, Drug Test, No Contact Drug Test, ToxDirect


Leave a Reply

Your email address will not be published. Required fields are marked *